神经退行性疾病的当前概念和分子病理学
Shelley L Forrest1, Gabor G Kovacs2
1Tanz Centre for Research in Neurodegenerative Disease, University of Toronto, Toronto, ON, Canada; Laboratory Medicine Program and Krembil Brain Institute, University Health Network, Toronto, ON, Canada; Dementia Research Centre, Macquarie Medical School, Faculty of Medicine, Health and Human Sciences, Macquarie University, Sydney, NSW, Australia.
Pathology
|December 13, 2024
概括
神经退行性疾病涉及错误折叠的蛋白质,如tau和β-粉样蛋白. 了解蛋白质结构和传播是准确诊断和开发新生物标志物的关键.
科学领域:
- 神经学 神经学
- 病理学 病理学 病理学
- 生物化学 生物化学
背景情况:
- 神经退行性疾病是多种多样的,标志着蛋白质错误折叠和沉积在神经元和神经中.
- 形状改变的蛋白质驱动疾病的发病,导致选择性神经元功能障碍和损失.
- 质细胞在大脑内的病理传播和进展模式中发挥着重要作用.
研究的目的:
- 审查神经退行性疾病的发病和诊断影响.
- 讨论分子和超结构分类,包括蛋白质丝结构.
- 为神经病理学家和临床医生强调基于蛋白质的分类的重要性.
主要方法:
- 对蛋白质构成和生物标志物的分子研究的审查.
- 分析解剖传播模式和质细胞参与的分析.
- 结合低温电子显微镜用于超结构分类.
主要成果:
- 错误折叠的蛋白质,如tau,粉样β,α-synuclein和TDP-43,是神经退行症的核心.
- 组合蛋白质沉积是常见的,即使在老年大脑中,也使解释复杂化.
- 蛋白质结构和扩散模式为分类提供了一个新的分层层次.
结论:
- 基于蛋白质的分类系统,包括分子和超结构数据,对于诊断神经退行性疾病至关重要.
- 了解混合病理和蛋白质传播对于准确的临床病理相关性至关重要.
- 全身解剖研究对于理解这些疾病的全谱和病原性至关重要.
相关概念视频
Parkinson's Disease: Overview
479
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
479
Alzheimer's Disease: Overview
447
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
447
Neural Regulation
39.1K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.1K
Disorders of the Nervous Tissue
1.1K
Nervous tissue is a vital component of the human body's communication system, enabling us to perceive and respond to stimuli. However, like all other tissues, it is vulnerable to disorders and diseases that can significantly impact our neurological functioning.
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises...
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises...
1.1K
Amyloid Fibrils
9.2K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.2K
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
453
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
453


